
Labubu-maker Pop Mart diversifies into jewellery with new concept store
SHANGHAI: "Blind box" toymaker Pop Mart, which has seen frenzied sales worldwide for products related to its ugly-cute Labubu character, opened its first jewellery store in Shanghai on Friday.
The jewellery concept store, called Popop, sells accessories adorned with Pop Mart's top-selling characters, including Labubu, Molly and Skullpanda.
While Chinese consumption remains subdued in the face of a prolonged property downturn and sluggish economy, Pop Mart's affordable and adorable toys have remained in high demand both domestically and internationally, driving its share price up more than 200 per cent so far this year.
Investor Zhang Ming, 34, who owns Pop Mart stocks worth 100 million yuan (US$13.92 million), flew from his base in the southwestern Chinese city of Chongqing for the opening to check out the new store concept and decide whether to increase his shareholding in the company.
"I believe that the pricing and target audience for this brand are particularly well-suited, and I am confident that Pop Mart could potentially become China's version of Disney," Zhang said, predicting that the company's market capitalisation could double from its current US$45.65 billion valuation.
Alongside some Disney characters and others related to anime, comics and popular video games, Pop Mart's characters are seen as fulfilling what has been called "emotional consumption" — where young consumers spend on affordable luxuries that bring joy into their lives.
Fang Ke, 35, who has a birthday coming up this month, decided to treat herself to a 699 yuan Labubu bracelet at the opening.
"I've loved Pop Mart for a long time; it's good-looking, brightly coloured, and also has a visual impact," she said. "My daughter likes it too."
At Popop, prices start at around 350 yuan for charms or a simple silver ring, and go as high as 2,699 yuan for necklaces adorned with metallic models of the characters. Most pieces are priced at under 1,000 yuan.
At a traditional Pop Mart store, the "blind box" toys the chain is best known for generally sell for 69 yuan and up, but consumers have shown a willingness to pay significantly more for limited editions.
Earlier this week, a Beijing auction house sold a human-sized Labubu figure for 1.08 million yuan, setting a new record and marking the toy's transition from craze to collectible.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Star
26 minutes ago
- The Star
With tragic plane crash, Air India's revamp to take longer
BENGALURU, (India): The crash of the London-bound Air India flight in Ahmedabad on Thursday (June 12) that left more than 265 dead could slow the erstwhile national carrier's plans to expand and revive its reputation and profitability. This is because it must turn its attention now to restoring internal morale and consumer confidence after the tragic accident. Officials are still investigating why AI171 crashed, but it is the airline's first wide-body aircraft accident in 40 years. The Tata Group bought the carrier from the Indian government in 2022. For Air India, which posted an operational profit in early June after decades of losses and hoped to reach full profitability by 2027, the crash changes many plans. The incident could result in significant losses for Air India not only because all except one of the 242 passengers were killed, but also because the airline may be held liable for the plane's plunge onto a medical hostel in a residential area. After the accident, Tata Sons chairman N. Chandrasekaran announced compensation of 10 million rupees (S$148,900) to the families of each person who lost their life. He also promised to cover the medical expenses of those injured and help reconstruct the B.J. Medical hostel the plane fell on. The airline is suffused with nostalgia with its turbaned Maharaja mascot and delicious Indian meals, and unsmiling but efficient crew. In recent years, however, it has become a butt of passenger ridicule for persistent delays, poorly maintained planes and years of losses. Under Tata ownership, Air India's chief executive Campbell Wilson is helming a five-year intensive transformation plan beginning in 2022 to revamp an ageing and outdated fleet, upskill staff, upgrade IT systems, and create a world-class airline on a par with rivals like Emirates. Air India's losses had been reduced by more than 40 per cent since the privatisation in January 2022 as it aimed to break even. It flew a total of 43.5 million passengers during the financial year April 2024 to March 2025. In April 2025, Air India announced a US$400 million (S$513.5 million) fleet upgrade programme for 106 of its 198 aircraft. This involved refurbishing seats, carpets, curtains and lavatories. The full-service carrier, which started making money in 2025, had made financial gains reportedly from cost cutting and streamlining operations, aided by lower fuel costs and a surge in passenger numbers. Sources close to the company said the airline was eyeing full profitability by 2027 once the low-cost arm of the group, Air India Express, which has been expanding its fleet, also increases its revenue. Wilson, a former CEO of Scoot, had reportedly informed employees during a townhall in June that Air India was advancing towards becoming 'a self-sustaining company'. The crash changes, if not all the well-laid plans, many of them. 'We are devastated. All of us are wondering what went wrong,' an Air India pilot, who has worked at the company for over 15 years, told ST, requesting anonymity. Aviation expert Sanjay Lazar, chief executive of Availalaz Consultants in Mumbai, said: 'A tragedy like this strikes at the heart of an airline. It will set the company back tremendously, as crashes do. 'The morale of personnel and external consumer trust will have to be rebuilt.' This is the first accident of an Air India wide-body aircraft since 1985, said Mr Lazar. The last Air India hull loss – which means an aviation accident that damages the aircraft beyond repair – was on June 23, 1985, when a London/Mumbai-bound flight from Montreal exploded due to a bomb planted by a Canadian Sikh terror group. Just 17 years old at the time, Lazar had lost his entire family in the 1985 crash, after which he trained to be a pilot and worked at Air India for 38 years. 'From 1985 to 2025, there has been no hull loss for Air India. Strong companies bounce back. Air India has a good safety record and robust systems that must be reinforced like in the past,' he told ST. Beyond the aftermath of the crash, headwinds in the form of trade tariffs imposed by the US, tensions on the India-Pakistan border and airspace closures from conflicts in other parts of the world such as the ongoing bombing of Iran by Israel remain concerns for the airline. Wilson told The Hindu in May that Air India has requested a subsidy worth US$600 million annually from the government to tide it over the financial hit from the closure of Pakistan's airspace and the resultant re-routings undertaken by the airline for its westbound flights. Relatives and hospital staff carry the body of a victim who died in an airplane crash in Ahmedabad, Gujarat, western India. - Photo: EPA-EFE The airspace closure in Iran worsens this situation. While the reason for the crash is yet unknown, it could also affect the aviation sector temporarily, as passengers put off travel, fearing the worst. The crash of the 12-year-old 787 Dreamliner has refuelled scrutiny of Boeing, whose safety reputation began to unravel in October 2018 when a Lion Air flight operating a 737 Max crashed due to a malfunction, killing 189 people. Just months later, in March 2019, an Ethiopian Airlines flight using the same aircraft model crashed for the same reason, killing all 157 people aboard. But until now, the 787 Dreamliner aircraft had maintained a relatively strong safety record, said aviation professional Hemanth D.P. Boeing's 787 was launched in 2011, and there are around 1,100 in the world. Air India owns an estimated 35 of them, not including the one that crashed. Some Indian media reports said the Ministry of Civil Aviation was considering grounding 787s for a safety review. Shortly after the crash, shares of Tata Group's companies saw an increase in selling pressure on June 12. However, analysts said it was sentiment-driven and that the long-term impact of the crash may be limited only to the Tata-owned airline business, and not extend to other entities. Air India operates as a standalone entity, and any liabilities arising from the crash, be it aircraft damage, compensation or lawsuits, are expected to be covered through aviation insurance, analysts who track aviation finance and safety told ST. Shares of Singapore Airlines, which holds a 25.1 per cent stake in Air India, dropped by 1.7 per cent on the Singapore Exchange. - The Straits Times/ANN


The Star
27 minutes ago
- The Star
Laos pushes to increase exports, earning US$977mil in five months of 2025
VIENTIANE: Laos earned US$977 million from agricultural exports in the first five months of 2025, reaching 65 percent of the Lao National Assembly's annual target of US$1.5 billion. The Lao government is accelerating efforts to strengthen agricultural exports and enforce stricter oversight of the mining industry in a bid to reduce import dependency, expand trade, and ensure sustainable economic development. Speaking at the ninth ordinary session of the Lao National Assembly's ninth legislature on Monday (June 9), Lao Prime Minister Sonexay Siphandone highlighted key achievements in agriculture and mining as part of the country's strategy to reduce import dependency and promote sustainable economic growth. To boost export competitiveness, the Lao government is expediting the construction of a modern slaughterhouse that meets international standards. This facility is expected to enhance the quality and marketability of the country's meat exports. In parallel with its agricultural initiatives, the government is intensifying oversight of the mining sector. In his speech, Sonexay reaffirmed the government's commitment to economic diversification and sustainable development, pledging continued reforms in both agriculture and natural resource management. - Xinhua


Malaysian Reserve
an hour ago
- Malaysian Reserve
Gene Solutions and Shenzhen USK Bioscience Forge Strategic Partnership to Establish Next-Generation Sequencing Laboratory in Southern China
SINGAPORE, June 14, 2025 /PRNewswire/ — Gene Solutions, a leading multinational biotechnology company and Shenzhen USK Bioscience Co., Ltd. (USKBio), a prominent innovator in molecular diagnostics, have entered a strategic partnership through a Memorandum of Understanding (MOU). The landmark agreement paves the way for the establishment of a state-of-the-art next generation sequencing (NGS) laboratory in southern China, advancing localized oncology diagnostics. The collaboration will leverage USKBio's existing infrastructure, and Gene Solutions' advanced next-generation AI & genomics capabilities to jointly establish a next-generation sequencing (NGS) laboratory. The lab will focus on accelerating access to early cancer detection and molecular residual disease (MRD) monitoring using AI-powered circulating tumor DNA (ctDNA) technologies, tailored to address the unique clinical needs of southern China's healthcare landscape. USKBio brings extensive expertise in Polymerase Chain Reaction (PCR)-based In Vitro Diagnostics (IVD) and Good Manufacturing Practice (GMP)-certified production capabilities. Gene Solutions contributes its leadership in NGS-based oncology applications, highlighted by its groundbreaking SPOT-MAS test — Asia's first clinically validated multi-cancer early detection (MCED) assay, validated through a prospective study of 9,024 participants. Additionally, Gene Solutions recently published a real-world MRD study involving 623 patients across six cancer types—lung, colorectal, breast, gastric, liver, and ovarian—demonstrating the clinical utility of ctDNA for monitoring treatment response and assessing recurrence risk. This partnership will focus on localizing and validating these cutting-edge technologies for the Chinese market while fostering joint R&D and production of advanced IVD medical devices. This alliance represents a major step forward in delivering accessible, high-impact, personalized cancer diagnostics to a broader population in China. 'This partnership with USKBio allows us to move quickly in establishing a high-impact oncology hub in southern China,' said Dr. Nguyen Hoai Nghia, CEO and Co-founder at Gene Solutions. 'Together, we aim to bring early, accurate, and scalable cancer screening and diagnostics to more patients, ultimately improving cancer outcomes.' 'Gene Solutions and USKBio are highly complementary in their core technologies, regional markets, and business models.' said Dr. Yu Dehua, CEO at USKbio. 'This strategic collaboration will leverage both parties' strengths, creating strong synergies to deliver greater benefits to cancer patients across the Asia region.' The partnership also includes technology transfer, technical training, and joint commercialization efforts to ensure rapid deployment and widespread adoption of these advanced genomic tools. About Shenzhen USKBio Founded in August 2015, Shenzhen USKBio is a national high-tech biological enterprise established by leading Chinese and American scientists and entrepreneurs. Specializing in in vitro molecular diagnostics, USKBio integrates R&D, production, marketing, and medical testing services, with a robust presence in IVD reagents, diagnostic instruments, and testing services. Leveraging proprietary technologies such as Udx-PCR and Udx-MSP, the company offers innovative solutions for early cancer screening, precision diagnosis, and companion diagnostics. With over 36 authorized patents and collaborations across top hospitals and testing institutions in China, USKBio is a rising leader in the global molecular diagnostics industry, dedicated to advancing precision medicine. About Gene Solutions Gene Solutions is a leading multinational biotechnology company headquartered in Asia, pioneering the integration of advanced AI and circulating tumor DNA (ctDNA) technologies to deliver innovative solutions across the cancer care continuum. Recognized for its proprietary research and CAP-accredited laboratories, the company combines multi-dimensional genomics with AI-driven analytics to transform oncology—from early detection to real-time treatment monitoring. With a strong regional presence and a commitment to empowering access to precision medicine, Gene Solutions is shaping the future of cancer diagnostics and personalized care across the Asia-Pacific. Explore more information at: